Skip to main content

Table 3 Comparison of trial pharmacists and independent pharmacist rating of MRP severity

From: Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations

Potential severity rating

IMeRSe (n = 354*)

PharMIbridge (n = 170)

 

Pharmacist rated

n (%)

Independent pharmacist rating

n (%)

Pharmacist rated

n (%)

Independent pharmacist rating

n (%)

High (S4)

99 (28.0)

2 (0.6)

15 (8.8)

2 (1.2)

Moderate (S3)

140 (39.6)

171 (48.3)

56 (32.9)

113 (66.5)

Mild (S2)

79 (22.3)

56 (15.8)

81 (47.7)

46 (27.1)

Low (S1)

27 (7.6)

102 (28.8)

15 (8.8)

2 (1.2)

Nil (S0)

9 (2.5)

23 (6.5)

3 (1.8)

7 (4.1)

Mean score (SD)

2.8 (1.0)

2.1 (1.0)

2.4 (0.8)

2.6 (0.7)

P-value#

p < 0.001

p = 0.008

  1. *Rating of MRP severity was introduced into the GuildCare NG™ module during the course of the trial (Feb 2019); data only available for Medicines Talks that took place after this date is compared (n = 354). # Paired t-test